CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS
· Delayed Price · Currency is USD
0.107
-0.006 (-5.56%)
At close: Dec 5, 2025
CERO Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 1.95 | 3.25 | 1.52 | 0.48 | 1.1 |
| Cash & Short-Term Investments | 1.95 | 3.25 | 1.52 | 0.48 | 1.1 |
| Cash Growth | -42.39% | 113.76% | 219.73% | -56.68% | - |
| Prepaid Expenses | 0.53 | 0.27 | 0.37 | 0.23 | 0.26 |
| Restricted Cash | 0.07 | 0.07 | 0.08 | 41.67 | - |
| Other Current Assets | - | 0.11 | - | - | - |
| Total Current Assets | 2.55 | 3.71 | 1.97 | 42.37 | 1.36 |
| Property, Plant & Equipment | 1.18 | 1.99 | 3.16 | - | - |
| Long-Term Deferred Tax Assets | - | - | - | - | 0.02 |
| Long-Term Deferred Charges | 0.17 | 0.5 | - | - | - |
| Other Long-Term Assets | - | - | - | - | 178.7 |
| Total Assets | 3.91 | 6.21 | 5.13 | 42.37 | 180.08 |
| Accounts Payable | 7.08 | 4.51 | 1.67 | 1.65 | 0.01 |
| Accrued Expenses | 0.34 | 1.91 | 0.14 | 0 | 0.08 |
| Short-Term Debt | - | - | 0.6 | 0.65 | - |
| Current Portion of Leases | 0.93 | 0.88 | 0.77 | - | - |
| Current Income Taxes Payable | - | - | - | 0.6 | - |
| Other Current Liabilities | 0.11 | 0.11 | 0.32 | 27.84 | - |
| Total Current Liabilities | 8.45 | 7.4 | 3.51 | 30.75 | 0.1 |
| Long-Term Leases | - | 0.7 | 1.58 | - | - |
| Other Long-Term Liabilities | - | - | - | 22.62 | 187.65 |
| Total Liabilities | 8.45 | 8.1 | 5.08 | 53.37 | 187.75 |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Additional Paid-In Capital | 73.06 | 67.14 | 1.03 | - | - |
| Retained Earnings | -86.3 | -70.92 | -43.09 | -11 | -7.67 |
| Comprehensive Income & Other | - | -1.3 | - | - | - |
| Total Common Equity | -13.24 | -5.07 | -42.06 | -11 | -7.67 |
| Shareholders' Equity | -4.54 | -1.89 | 0.04 | -11 | -7.67 |
| Total Liabilities & Equity | 3.91 | 6.21 | 5.13 | 42.37 | 180.08 |
| Total Debt | 0.93 | 1.58 | 2.94 | 0.65 | - |
| Net Cash (Debt) | 1.02 | 1.68 | -1.42 | -0.17 | 1.1 |
| Net Cash Per Share | 2.04 | 65.70 | - | -15.48 | - |
| Filing Date Shares Outstanding | 21.1 | 0.27 | - | - | 0.01 |
| Total Common Shares Outstanding | 1.5 | 0.12 | - | - | 0.01 |
| Working Capital | -5.9 | -3.69 | -1.54 | 11.62 | 1.26 |
| Book Value Per Share | -8.85 | -41.98 | - | - | -667.47 |
| Tangible Book Value | -13.24 | -5.07 | -42.06 | -11 | -7.67 |
| Tangible Book Value Per Share | -8.85 | -41.98 | - | - | -667.47 |
| Machinery | 2.55 | 2.55 | 2.55 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.